Hyloris Pharmaceuticals Quote - HYL

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

5.30

Bid

5.26

Ask

5.60

Volume

7,692

5.26 Day's Range 5.60

2.89 52 Week Range 13.30

Market Cap

148.4M

Previous Close

5.54

Open

5.60

Last Trade

5.3

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

14,008

Shares Outstanding

28,000,000

Dividend Yield

PE Ratio

-9.65

Earnings Per Share (EPS)

-0.55

Revenue

4.21M

Net Profit

-15.38M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hyloris.com

Headquarters

Liege, Liege, Bel

Founded

Hyloris Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker HYL. The last closing price for Hyloris Pharmaceuticals was 5.54 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 2.89 € to 13.30 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. The market capitalization of Hyloris Pharmaceuticals is 155.12 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -9.65.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.62	-10.472972973	5.92	6	5.26	10272	5.80264943	DE
4	-0.5	-8.62068965517	5.8	6	4.86	11773	5.72007058	DE
12	-0.3	-5.35714285714	5.6	6.2	3.06	14008	5.32927392	DE
26	-6.4	-54.7008547009	11.7	11.7	2.89	18135	5.66188723	DE
52	-5.9	-52.6785714286	11.2	13.3	2.89	13453	7.71928258	DE
156	-11.6	-68.6390532544	16.9	19.1	2.89	7755	10.36322004	DE
260	-5.45	-50.6976744186	10.75	19.1	2.89	9143	11.16546045	DE

HYL - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?

The current share price of Hyloris Pharmaceuticals is 5.30 €

How many Hyloris Pharmaceuticals shares are in issue?

Hyloris Pharmaceuticals has 28,000,000 shares in issue

What is the market cap of Hyloris Pharmaceuticals?

The market capitalisation of Hyloris Pharmaceuticals is EUR 155.12M

What is the 1 year trading range for Hyloris Pharmaceuticals share price?

Hyloris Pharmaceuticals has traded in the range of 2.89 € to 13.30 € during the past year

What is the PE ratio of Hyloris Pharmaceuticals?

The price to earnings ratio of Hyloris Pharmaceuticals is -9.65

What is the cash to sales ratio of Hyloris Pharmaceuticals?

The cash to sales ratio of Hyloris Pharmaceuticals is 35.22

What is the reporting currency for Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals reports financial results in EUR

What is the latest annual turnover for Hyloris Pharmaceuticals?

The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M

What is the latest annual profit for Hyloris Pharmaceuticals?

The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M

What is the registered address of Hyloris Pharmaceuticals?

The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000

What is the Hyloris Pharmaceuticals website address?

The website address for Hyloris Pharmaceuticals is www.hyloris.com

Which industry sector does Hyloris Pharmaceuticals operate in?

Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMBSZTME Pharma NV	0.02 € (185.71%)	132.5k
MLGEQGentlemen S Equity SA	0.0175 € (118.75%)	1.14k
ALCYBCybergun	0.0002 € (100.00%)	17.54M
MLAAHAmatheon Agri Holding NV	0.0185 € (54.17%)	40.1k
ALARFAdeunis	0.94 € (28.77%)	5.27k
MLSMLSmalto	0.0125 € (-37.50%)	2.34k
MLFTIFrance Tourisme Immobilier	0.025 € (-35.90%)	56.77k
CNVCnova NV	0.209 € (-19.62%)	26.38k
MLWEAWeaccess Group	0.382 € (-16.96%)	5.95k
ALEUPEuroplasma	0.0353 € (-15.95%)	3.16M
ATOAtos SE	0.0021 € (0.00%)	2.71B
BCPBanco Comercial Portugues SA	0.4493 € (-0.69%)	66.54M
ALHGLouis Hachette Group	1.3342 € (4.87%)	52.04M
KPNKoninklijke KPN NV	3.509 € (-1.21%)	26.9M
VIVVivendi SE	2.51 € (2.41%)	26.39M